Longevity Swap: How Pension Plans Hedge Life Expectancy Risk

Key Takeaways

• Longevity swap transfers the mortality trajectory risk from a pension plan to a reinsurer; a one-year increase in assumed life expectancy for a mature UK DB plan can raise liabilities by roughly 3–5 percent.
• UK de-risking volumes routinely exceed £50 billion per year across longevity swaps, buy-ins, and buyouts, making it the world's most developed longevity risk transfer market.
• A common mistake is conflating a longevity swap with a buy-out; a swap stays on the plan's balance sheet and transfers only longevity risk, while a buy-out removes the liability entirely at much higher cost.
• Collateral posting requirements on a 20- to 30-year swap can swing materially with discount-rate and mortality-assumption updates, creating a liquidity cost that many pension schemes underestimate at inception.

What It Is

A longevity swap is an over-the-counter derivative where one counterparty, typically a defined-benefit pension scheme or an insurer, exchanges a fixed stream of payments, based on a pre-agreed expected mortality table, for a floating stream of payments based on the actual mortality experience of a reference population. If members live longer than expected, the pension plan receives larger floating payments from the counterparty, offsetting its higher-than-expected annuity obligations.

The counterparty is usually a reinsurer. Global longevity swap volumes have grown steadily since the first landmark UK transaction in 2009. The UK remains the dominant market, where the Pensions Regulator tracks annual de-risking volumes across longevity swaps, buy-ins, and buyouts. Market volumes routinely exceed 50 billion pounds per year in recent cycles.

The Intuition

Pension plans face two kinds of future uncertainty. One is investment return, which they hedge with bonds and derivatives. The other is longevity: whether their current retirees and active members live materially longer than assumed. A one-year increase in assumed life expectancy for a mature UK DB plan can raise liabilities by roughly 3 to 5 percent. Over decades, small assumption errors compound into huge funding holes.

A longevity swap removes that risk. The plan keeps its assets and its investment decisions but hands the mortality trajectory to a reinsurer that specializes in pooling longevity risk across many schemes, territories, and age cohorts. The counterparty can diversify in ways a single plan cannot, and it is paid for the service through a spread built into the fixed leg.

How It Works

A typical longevity swap structure has four components:

1. Reference population. The scheme defines the members covered, usually all current pensioners and sometimes also deferred members. Dependants are often included. The population is fixed at inception; the swap pays on that defined group.
2. Fixed leg. A pre-agreed schedule of monthly or annual payments reflecting expected benefit outflows based on negotiated mortality assumptions, often built from the scheme's own mortality experience plus industry tables from bodies such as the Continuous Mortality Investigation in the UK. Includes a margin for the counterparty.
3. Floating leg. The actual benefit outflows required for the defined population, reset as deaths occur. If more members die than expected, the floating leg shrinks; if fewer die, it grows.
4. Collateral. Both sides post collateral daily against mark-to-market exposure, similar to an interest rate swap. Credit Support Annex terms typically require government bonds or cash.

Most transactions are indemnity-based, meaning the floating leg mirrors the scheme's actual experience. A smaller number are index-based, paying on national mortality indices, which is simpler but introduces basis risk.

The reinsurer often retrocedes a slice of the risk to other reinsurers or, in some cases, to capital-market investors via longevity-linked notes. True capital-market longevity bonds have been attempted (BNP/EIB 2004) but have not yet established a liquid market.

Worked Example

Consider a UK corporate pension scheme with 5 billion pounds of liabilities, of which 3 billion relates to current pensioners. The trustees execute an indemnity longevity swap covering 3 billion of pensioner liabilities with a global reinsurer.

Year 1 expected cashflows are 180 million pounds, based on the negotiated best estimate plus a 2 percent reinsurer margin. The scheme pays 180 million to the reinsurer on the fixed leg. The reinsurer pays out 176 million to cover actual pensions, because mortality ran slightly higher than expected. Net flow for the year: the scheme paid 4 million more than needed. The margin covered the reinsurer's risk loading.

Over 20 years, assume an unexpected improvement in mortality due to medical advances. Actual pension outflows run 8 percent higher than the expected pattern. Without the swap, the scheme would face a liability increase of hundreds of millions. With the swap, the reinsurer absorbs the cost: the floating leg pays out the realized cashflows, exactly matching the scheme's obligations. The scheme has locked in its cost of longevity in exchange for the upfront margin.

If mortality instead runs lower than expected (people die sooner), the reinsurer earns more than its expected margin. That asymmetry is part of the calculus on both sides.

Common Mistakes

1. Confusing longevity swap with buy-out. A longevity swap transfers only longevity risk and is on balance sheet for the scheme. A buy-out transfers all obligations to an insurer, removes the liability from the sponsor's balance sheet, and is much more expensive. Schemes often use longevity swaps as a step toward eventual buy-out.

2. Underestimating basis risk in index-based swaps. A national mortality index does not match any specific scheme's population. Schemes with unusual socioeconomic profiles (for example, very white-collar or blue-collar) can see significant basis risk between scheme experience and the index.

3. Ignoring collateral volatility. Mark-to-market on a 20- or 30-year swap can swing materially with discount-rate and mortality-assumption updates. Collateral posting is a liquidity cost that many schemes underestimate at inception.

4. Treating the margin as optional. Competitive pricing tightens, but reinsurers charge for risk, capital, and operational costs. A margin that looks thin today may reflect stringent assumptions; a very aggressive bid sometimes signals modeling differences that will surface later.

5. Missing reinsurer concentration risk. A handful of reinsurers dominate UK longevity reinsurance, notably Pacific Life Re, Prudential, Swiss Re, Munich Re, and RGA. Concentration at a counterparty level can matter at a market level, particularly if a major player pulls back during a rate shock or capital event.

Frequently Asked Questions

Q: What is a longevity swap in simple terms? A longevity swap is an over-the-counter derivative where a pension plan pays a fixed schedule of expected benefit cashflows to a reinsurer and receives the actual cashflows needed to pay its surviving members. If members live longer than expected, the reinsurer covers the extra cost; if they die sooner than expected, the reinsurer keeps the surplus. The plan transfers longevity risk in exchange for a margin embedded in the fixed leg.

Q: How does a longevity swap affect investment decisions? For pension scheme sponsors and insurance companies, a longevity swap reduces earnings and funding volatility from mortality assumption changes. It makes reported liabilities more predictable and can lower the sponsor's pension deficit risk at the cost of paying an ongoing margin. For institutional investors, longevity risk exposure is available through ILS structures and longevity-linked notes, offering a return stream uncorrelated to markets.

Q: What is a real-world example of longevity swap analysis? In the worked example, a UK corporate scheme executes a £3 billion indemnity longevity swap. Year one expected cashflows are £180 million; actual mortality runs slightly higher than expected so the scheme's net payment is £4 million above what it needed to pay out. Over 20 years, if medical advances add 8 percent to actual pension outflows, the reinsurer absorbs hundreds of millions in extra payments that would otherwise fall on the scheme.

Q: How can investors use longevity swap analysis? For pension-investing: assess whether a scheme's longevity swap adequately covers all pensioner and deferred member liabilities, and check whether an indemnity or index-based structure is used, the latter introduces basis risk. For insurance company analysis: monitor the reinsurer's longevity book size, since a large concentration in UK or US longevity reinsurance creates correlated exposure to pandemic-type mortality shocks.

Q: How is a longevity swap different from a pension buy-out? A longevity swap transfers only mortality trajectory risk and keeps all assets, investment management, and remaining obligations on the plan's balance sheet. A buy-out transfers the entire liability, every promise to every member, to a regulated insurance company, which then holds assets and manages the pension independently. Buy-outs permanently remove the liability from the corporate sponsor's balance sheet at a significantly higher premium than a longevity swap.

Sources

1. UK Pensions Regulator. "De-risking and the bulk annuity market." https://www.thepensionsregulator.gov.uk/
2. Life and Longevity Markets Association. "Standards and Resources." https://www.llma.org/
3. Hymans Robertson. "Risk Transfer Reports." https://www.hymans.co.uk/insights/reports-and-publications/
4. International Monetary Fund. "Global Financial Stability Report, Longevity Risk chapter." https://www.imf.org/en/Publications/GFSR

Disclaimer

This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.